ACOR - Acorda Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $173.31. This is a potential upside of $172.65 (26159.09%) from yesterday's end of day stock price of $0.66.

Acorda Therapeutics's activity chart (see below) currently has 40 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.43% with an average time for these price targets to be met of 87.57 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 17-Jun-2021. First documented stock forecast 24-Sep-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$200

$198.8 (16566.67%)

$3960

3 years 3 months 18 days ago

0/4 (0%)

$103 (106.19%)

Buy

$100

$98.8 (8233.33%)

$3600

3 years 8 months 22 days ago

2/4 (50%)

$-22.4 (-18.30%)

139

Hold

$120

$118.8 (9900.00%)

$2280

4 years 4 months 29 days ago

5/5 (100%)

$16.79 (16.27%)

44

Hold

$120

$118.8 (9900.00%)

$3000

4 years 4 months 29 days ago

6/6 (100%)

$16.79 (16.27%)

45

Sell

$120

$118.8 (9900.00%)

$1200

4 years 11 months 14 days ago

7/7 (100%)

$-165.6 (-57.98%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACOR (Acorda Therapeutics) average time for price targets to be met?

On average it took 87.57 days on average for the stock forecasts to be realized with a an average price target met ratio 61.43

Which analyst has the current highest performing score on ACOR (Acorda Therapeutics) with a proven track record?

THOMAS SHRADER

Which analyst has the current lower performing score on ACOR (Acorda Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on ACOR (Acorda Therapeutics)?

Thomas Shrader works at BTIG and has 10 price targets and 8 ratings on ACOR

Which analyst is the currently most bullish on ACOR (Acorda Therapeutics)?

Thomas Shrader with highest potential upside - $1785.51

Which analyst is the currently most reserved on ACOR (Acorda Therapeutics)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?